An investigation of the nature of bladder mucosal glycoconjugates and their role in interstitial cystitis

被引:0
|
作者
Bhavanandan, VP [1 ]
Erickson, DR [1 ]
机构
[1] PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT SURG,HERSHEY,PA 17033
来源
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The long-term objective of this study is to elucidate the role of bladder mucosal glycosaminoglycans and mucin glycoproteins in the development of interstitial cystitis and other bladder diseases. Bladder biopsies and urine samples from patients and healthy controls were analyzed for glycoconjugates by biochemical and immunochemical methods. Due to the limited availability of human bladders for research purposes, detailed analysis of rabbit bladders glycoconjugates were also carried out. Biochemical analysis of rabbit bladders indicate that while the major portion of the glycoconjugates in the urothelium is sialoglycoprotein, low levels of heparan sulfate and chondroitin sulfate are also immunohistochemical data show very weak staining of the rabbit antiglycosaminoglycan antibodies. In contrast, the lamina propria and muscle layers stained intensely for chondroitin sulfate and hyaluronic acid. Thus, the quantity of glycosaminoglycans associated with the bladder epithelial layer, particularly as extracellular matrix components on the luminal surface of the bladder, appears insignificant. On the other hand, several lectins and anti-epitectin (a MUC1 sialoglycoprotein) antibodies showed strong staining of the luminal surface of rabbit and normal human bladders. Further, preliminary results with anti-epitectin antibodies reveal a weaker and patchy staining of biopsy specimens from interstitial cystitis patients compared to controls. The urinary levels of glycosaminoglycans and epitectin, in interstitial cystitis patients and healthy controls were determined by chemical or immunoassays. Urinary epitectin, but not glycosaminoglycans, was decreased in interstitial cystitis patients.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [1] Role of cystoscopy as primary initial investigation in interstitial cystitis/bladder pain syndrome
    Singh, Angadjot
    Priyadarshi, Shivam
    Bansal, Somendra
    Nandwani, Sanyam
    UROLOGIA JOURNAL, 2024, 91 (01) : 189 - 193
  • [2] Role of inflammation in bladder function and interstitial cystitis
    Grover, Sonal
    Srivastava, Abhishek
    Lee, Richard
    Tewari, Ashutosh K.
    Te, Alexis E.
    THERAPEUTIC ADVANCES IN UROLOGY, 2011, 3 (01) : 19 - 33
  • [3] Role of liposome in treatment of overactive bladder and interstitial cystitis
    Hung, Shih-Ya
    Chancellor, David D.
    Chancellor, Michael B.
    Chuang, Yao-Chi
    UROLOGICAL SCIENCE, 2015, 26 (01) : 3 - 6
  • [4] Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function
    Mostafa M. Mostafa
    Mostafa Kamel
    Mohamed Kamel
    Ayman Mahdy
    Current Bladder Dysfunction Reports, 2024, 19 : 16 - 26
  • [5] Beyond brooke to the bladder - a role for honey in Interstitial cystitis?
    Birch, B. R. P.
    Murray, T.
    Cooper, A.
    Lwaleed, B. A.
    BRITISH JOURNAL OF SURGERY, 2011, 98 (06) : E5 - E5
  • [6] Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function
    Mostafa, Mostafa M.
    Kamel, Mostafa
    Kamel, Mohamed
    Mahdy, Ayman
    CURRENT BLADDER DYSFUNCTION REPORTS, 2024, 19 (01) : 16 - 26
  • [7] Mucosal Muscarinic Receptors Enhance Bladder Activity in Cats With Feline Interstitial Cystitis
    Ikeda, Y.
    Birder, L.
    Buffington, C.
    Roppolo, J.
    Kanai, A.
    JOURNAL OF UROLOGY, 2009, 181 (03): : 1415 - 1422
  • [8] Overactive bladder and interstitial cystitis
    Tamsin Osborne
    Nature Clinical Practice Urology, 2006, 3 (1): : 8 - 8
  • [9] BLADDER ANTIBODIES IN INTERSTITIAL CYSTITIS
    SILK, MR
    JOURNAL OF UROLOGY, 1970, 103 (03): : 307 - &
  • [10] Current role of neuromodulation in bladder pain syndrome/interstitial cystitis
    Padilla-Fernandez, Barbara
    Hernandez-Hernandez, David
    Castro-Diaz, David M.
    THERAPEUTIC ADVANCES IN UROLOGY, 2022, 14